Geisler JP - Search Results

1

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.

Geisler JP, Goodheart MJ, Sood AK, Holmes RJ, Hatterman-Zogg MA, Buller RE. Geisler JP, et al. Cancer. 2003 Nov 15;98(10):2199-206. doi: 10.1002/cncr.11770. Cancer. 2003. PMID: 14601090 Free article.

2

Frequency of BRCA1 dysfunction in ovarian cancer.

Geisler JP, Hatterman-Zogg MA, Rathe JA, Buller RE. Geisler JP, et al. J Natl Cancer Inst. 2002 Jan 2;94(1):61-7. doi: 10.1093/jnci/94.1.61. J Natl Cancer Inst. 2002. PMID: 11773283

3

Failure of BRCA1 dysfunction to alter ovarian cancer survival.

Buller RE, Shahin MS, Geisler JP, Zogg M, De Young BR, Davis CS. Buller RE, et al. Among authors: geisler jp. Clin Cancer Res. 2002 May;8(5):1196-202. Clin Cancer Res. 2002. PMID: 12006538

4

Inactivation of BRCA1 and BRCA2 in ovarian cancer.

Hilton JL, Geisler JP, Rathe JA, Hattermann-Zogg MA, DeYoung B, Buller RE. Hilton JL, et al. Among authors: geisler jp. J Natl Cancer Inst. 2002 Sep 18;94(18):1396-406. doi: 10.1093/jnci/94.18.1396. J Natl Cancer Inst. 2002. PMID: 12237285

5

Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.

Sood AK, Lush R, Geisler JP, Shahin MS, Sanders L, Sullivan D, Buller RE, Sorosky JI. Sood AK, et al. Among authors: geisler jp. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6080-5. doi: 10.1158/1078-0432.CCR-04-0574. Clin Cancer Res. 2004. PMID: 15447993 Clinical Trial.

6

Malignant mixed mullerian tumor of the ovary and bilateral breast cancer: an argument for BRCA3, or a coincidental cluster of unconnected cancers?

Burns BA, Geisler JP, Hatterman-Zogg MA, De Young B, Buller RE. Burns BA, et al. Among authors: geisler jp. Gynecol Oncol. 2003 Nov;91(2):426-8. doi: 10.1016/s0090-8258(03)00438-4. Gynecol Oncol. 2003. PMID: 14599878

7

Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP).

Geisler JP, Hatterman-Zogg MA, Rathe JA, Lallas TA, Kirby P, Buller RE. Geisler JP, et al. Hum Mutat. 2001 Oct;18(4):337-44. doi: 10.1002/humu.1195. Hum Mutat. 2001. PMID: 11668617

8

CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.

Kim SC, Ju W, Mahavni V, Geisler JP, Buller RE. Kim SC, et al. Among authors: geisler jp. Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:190-4. doi: 10.1111/j.1525-1438.2006.00300.x. Int J Gynecol Cancer. 2006. PMID: 16515589

9

Late recurrence of juvenile granulosa cell tumor of the ovary.

Frausto SD, Geisler JP, Fletcher MS, Sood AK. Frausto SD, et al. Among authors: geisler jp. Am J Obstet Gynecol. 2004 Jul;191(1):366-7. doi: 10.1016/j.ajog.2003.09.019. Am J Obstet Gynecol. 2004. PMID: 15295395

10

Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration.

Geisler JP, Manahan KJ, Buller RE. Geisler JP, et al. Gynecol Oncol. 2006 Jan;100(1):53-7. doi: 10.1016/j.ygyno.2005.06.068. Epub 2005 Oct 27. Gynecol Oncol. 2006. PMID: 16257042 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page